ArticleBioinformatics (Oxford, England)2026
ConfRetro: a 3D-aware template-free method for enhancing retrosynthesis via molecular conformer information.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationRetrosynthesis plays a crucial role in organic synthesis and drug discovery, focusing on identifying a set of reactants capable of synthesizing a target product molecule. Although the existing approaches have shown promising results, they do not fully exploit 3D conformer information and molecular spatial structure, which can hinder stereochemically consistent and chemically plausible predictions.
resultsTo tackle this problem, we propose ConfRetro, a Transformer-based template-free method that integrates molecular conformer information and spatial structure. We devise an Atom-align Fusion module to combine 3D positional information at the model input stage, ensuring alignment between atom tokens and corresponding 3D representations. Furthermore, we design a Distance-weighted Attention mechanism to guide self-attention, constraining the receptive field of model and emphasizing chemically relevant atom pairs in 3D space. Experiments conducted on the USPTO-50K and USPTO-FULL datasets demonstrate that ConfRetro significantly outperforms existing template-free approaches, achieving a new state-of-the-art performance. Case studies further highlight its capability to predict accurate and chemically plausible reactants, even for target molecules with intricate structures. Moreover, when plugged into a standard retrosynthetic search, ConfRetro recovers feasible synthetic routes for multiple representative drug molecules (e.g. Camptothecin). AVAILABILITY AND IMPLEMENTATION: ConfRetro is available at https://github.com/Jesse-zjx/ConfRetro. Archival snapshot is available at https://doi.org/10.5281/zenodo.20785018.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.